Q3 2017 13F Holders as of 30 Sep 2017
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
17,150,443
-
Share change
-
-1,294,281
-
Total reported value
-
$35,949,000
-
Price per share
-
$2.10
-
Number of holders
-
38
-
Value change
-
-$3,665,932
-
Number of buys
-
17
-
Number of sells
-
21
Institutional Holders of PROTEOSTASIS THERAPEUTICS IN - COM (PTI) as of Q3 2017
As of 30 Sep 2017,
PROTEOSTASIS THERAPEUTICS IN - COM (PTI) was held by
38 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
17,150,443 shares.
The largest 10 holders included
Cormorant Asset Management, LLC, NEA Management Company, LLC, JENNISON ASSOCIATES LLC, JPMORGAN CHASE & CO, Hillhouse Capital Management, Ltd., FMR LLC, Marshall Wace North America L.P., FIL Ltd, VANGUARD GROUP INC, and Rock Springs Capital Management LP.
This page lists
38
institutional shareholders reporting positions in this security
for the Q3 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.